Mesna

Known as: Ethanesulfonic acid, 2-mercapto-, monosodium salt, Sodium 2-Mercaptoethanesulphonate, 2-Mercaptoethanesulphonate, Sodium 
A sulfhydryl compound that is used to reduce the incidence of hemorrhagic cystitis associated with certain chemotherapeutic agents. Mesna is… (More)
National Institutes of Health

Topic mentions per year

Topic mentions per year

1971-2017
05019712017

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
Highly Cited
2008
Highly Cited
2008
We evaluated the feasibility and safety of therapy with mesenchymal stem cells (MSCs) through consecutively intra-arterial and… (More)
Is this relevant?
Highly Cited
2006
Highly Cited
2006
Clinical differentiation of parkinsonian syndromes such as the Parkinson variant of multiple system atrophy (MSA-P) and… (More)
  • figure 1
  • table 1
  • table 3
  • figure 2
  • table 4
Is this relevant?
Highly Cited
2004
Highly Cited
2004
BACKGROUND We used intravascular ultrasound (IVUS) to evaluate recurrence after sirolimus-eluting stent (SES) implantation… (More)
  • table 1
  • table 2
Is this relevant?
2003
2003
The effect of type 1 diabetes on bone healing and bone formation in standardized craniotomy defects created in BALB/cByJ mice was… (More)
  • figure 1
  • table 1
  • figure 2
  • figure 3
  • figure 4
Is this relevant?
Highly Cited
2002
Highly Cited
2002
OBJECTIVE AND BACKGROUND Routine MRI as well as MR volumetry and MRS have been shown to contribute to the differential diagnosis… (More)
Is this relevant?
Highly Cited
2000
Highly Cited
2000
It has been suggested that phytosterol and phytostanol esters possess similar cholesterol-lowering properties, however, whether… (More)
  • table 1
  • figure 1
  • table 2
  • figure 3
  • figure 2
Is this relevant?
Highly Cited
1993
Highly Cited
1993
PURPOSE AND METHODS Doxorubicin alone or with dacarbazine (DTIC; AD) is considered the best available therapy for metastatic… (More)
Is this relevant?
Highly Cited
1989
Highly Cited
1989
European and American investigators have reported response rates of 38% to 83% for ifosfamide alone in pretreated sarcomas. In a… (More)
Is this relevant?
1987
1987
We monitored acute tubular damage in 16 patients who received a 5-day course of ifosfamide (1.6 g/m2/day) and mesna (1.2 g/m2/day… (More)
Is this relevant?
1986
1986
Ifosfamide and mesna were administered to 77 patients with advanced malignancies. Seven (9%) experienced a severe but reversible… (More)
Is this relevant?